Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-17

FDA Approved: ONDANSETRON — Supplemental Application (Eugia US LLC)

View source ↗

Summary

The FDA approved a supplemental application for ondansetron hydrochloride from Eugia US LLC (ANDA 202599), granting regulatory approval for this generic product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)